FDA Approves Epkinly

FDA Approves Epkinly (epcoritamab-bysp) Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) NORTH CHICAGO, Ill., May 19, 2023 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp), as the first and only T-cell engaging bispecific antibody for the treatment of adult patients with […]

Read more

FDA Approves Uzedy

FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults PARSIPPANY, N.J., TEL AVIV & PARIS, April 28, 2023 – Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced today that the U.S. Food and Drug Administration (FDA) has approved Uzedy (risperidone) extended-release injectable suspension for […]

Read more

FDA Approves RizaFilm

FDA Approves RizaFilm (rizatriptan) Oral Film for the Treatment of Acute Migraine SAINT LAURENT, Quebec, April 17, 2023 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”), a leader in pharmaceutical films, today announced that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s RizaFilm® VersaFilm® 505(b)(2) new drug application (NDA) for the treatment of acute migraine.1 […]

Read more

Idaho Dropped Thousands From Medicaid in the Pandemic’s First Years

During the first two years of the covid-19 pandemic, while the federal government was trying to prevent people on Medicaid from losing health coverage, Idaho dropped nearly 10,000 people from the safety-net program. Federal law generally banned states from dropping people, and federal officials said Idaho acted improperly. Idaho officials, however, said they didn’t think they did anything wrong. The […]

Read more

California Attorney General Sues Drugmakers Over Inflated Insulin Prices

California Attorney General Rob Bonta on Thursday sued the six major companies that dominate the U.S. insulin market, ratcheting up the state’s assault on a profitable industry for artificially jacking up prices and making the indispensable drug less accessible for diabetes patients.  The 47-page civil complaint alleges three pharmaceutical companies that control the insulin market — Eli Lilly and Co., […]

Read more

Por qué algunos estados quieren garantizar Medicaid para los niños desde que nacen hasta los 6 años

Antes de que comenzara la emergencia de salud pública por covid-19 en 2020, millones de niños entraban y salían de Medicaid cada año, un indicio de que muchos perdían la cobertura por problemas administrativos, y no porque sus familias ganaran más y ya no fueran elegibles. Ahora, varios estados del oeste del país, como California, buscan cambiar esta situación con […]

Read more

Journalists Discuss Cracks in the Health Care System and Roadblocks to Covid Booster Shots

KHN senior correspondent Sarah Jane Tribble discussed her reporting for the podcast “Where It Hurts” on the “Too Long Didn’t Listen” podcast Feb. 3. Click here to hear Tribble on “Too Long Didn’t Listen“ Listen to “Where It Hurts“ KHN senior correspondent and enterprise reporter Liz Szabo discussed the problems immunocompromised people face in accessing a fourth covid-19 vaccine shot […]

Read more

Death in Dallas: One Family’s Experience in the Medicaid Gap

For years, Millicent McKinnon of Dallas went without health insurance. She was one of roughly 1 million Texans who earn too much to qualify for Medicaid in the state but too little to buy their own insurance. That is, until she died in 2019. She was 64 and had been unable to find consistent care for her breast cancer. Lorraine […]

Read more

Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief

President Joe Biden’s failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it’s baffling for the agency to be without a permanent leader during a national health crisis. The pandemic has taxed the FDA, an 18,000-person agency whose chiefs have traditionally received bipartisan backing […]

Read more
1 2 3 16